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Arterial tissue transcriptional 
profiles associate with tissue 
remodeling and cardiovascular 
phenotype in children with end-
stage kidney disease
Christian Freise  1, Betti schaefer2, Maria Bartosova2, Aysun Bayazit3, Ulrike Bauer4, 
Thomas pickardt4, Felix Berger4, Lars Melholt Rasmussen5, pia søndergaard Jensen5, 
Guido Laube6, Francesca Mencarelli7, Klaus Arbeiter8, Rainer Büscher9, sandra Habbig10, 
Kristina Möller11, Marietta Kirchner12, Franz schaefer2, Claus peter schmitt2 & Uwe Querfeld1
Chronic kidney disease (CKD) greatly increases the risk for cardiovascular disease (CVD). However, 
molecular mechanisms underlying CKD-induced arterial remodeling are largely unknown. We performed 
a systematic analysis of arterial biopsies from children with stage 5 predialysis CKD participating in the 
Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4 C) study. For comparison, we 
studied biopsies from children without CKD, coronary bypass vessels from adults with atherosclerotic 
coronary heart disease without CKD and aortic sections of subtotally nephrectomized rats. In pediatric 
CKD patients, gene expression was correlated to the cardiovascular phenotype assessed by surrogate 
end-points. The arterial calcium content correlated with the intima-media thickness (IMT) of biopsied 
vessels from pediatric CKD patients, was markedly increased compared to biopsies from children 
without CKD and comparable to adult coronary bypass patients. Significant transcriptional changes 
included ECM components, pro-calcifying factors, and physiological calcification inhibitors; most were 
highly accordant with changes observed in adults with atherosclerosis and in uremic rats. Individual 
gene expression levels were significantly associated with the left ventricular mass index and carotid 
intima media thickness. Thus, inflammatory processes (TNF, IL-10), calcification inhibitors (CA2), the 
Wnt-pathway (FGF-2) and foremost, ECM components (HMGA1, VNN1, VCAN), impact pathobiological 
responses in arteries from children with CKD.
Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease (CVD) and greatly 
increases the risk for cardiovascular events in patients of all ages. The arterial system is particularly affected by 
CKD as evidenced by the frequent development of vascular calcifications, which are observed even in children1–3. 
Vascular calcifications are promoted by a plethora of risk factors occurring in CKD, but are considered late events 
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in a process of vascular remodeling that seems to involve the entire arterial system4–6. In contrast, little is known 
about the earliest stages of CKD-associated systemic vascular disease.
Pediatric patients with CKD comprise only a small fraction of the total CKD population, but appear uniquely 
suited to study the effects of “native CKD” on the cardiovascular system due to the virtual absence of vascular 
morbidity related to ageing, diabetes and life-style related factors such as smoking. In an ongoing prospective 
observational study, the Cardiovascular Comorbidity in Children with CKD (4 C) study, a consortium of pediat-
ric nephrologists in Europe has joined to investigate the evolution of CVD of children as they advance through 
successive stages of CKD7,8.
We have performed an ex-vivo study of arterial biopsies obtained prior to dialysis initiation or transplantation 
from children participating in the 4 C study who had progressed to end-stage kidney disease (ESKD). The aim of 
the study was to characterize the origins of CKD-related arterial disease in this unique population.
Arterial biopsies were analyzed for morphological abnormalities, calcium contents and gene transcription lev-
els (customized PCR array for 88 selected genes). To specify CKD-associated changes, results were compared to 
arterial biopsies from children undergoing vascular surgery and to biopsies taken from adults with coronary heart 
disease. To further assess the generalizability of the transcriptional changes observed in the CKD specimens, 
we compared the human findings with those obtained in arteries of rats with subtotal nephrectomy, a standard 
rodent CKD model. Moreover, we explored potential associations of the tissue level findings with the clinical phe-
notype as characterized by surrogate markers of CVD, measured at baseline and during follow-up of the 4 C study.
Methods
Study populations. Children aged 6–17 years with a GFR of 10–60 ml/min/1.73 m2 (calculated at the time 
of enrollment using a cystatin C/creatinine-based formula9) not yet receiving renal replacement therapy were 
eligible for the ongoing observational 4 C study, which is prospectively following 688 pediatric patients with 
CKD at 55 pediatric nephrology centers in 12 European countries (Clin Trials.gov NCT01046448). All patients 
undergo annual cardiovascular assessments including carotid ultrasound, PWV measurement, echocardiography 
and 24-hour ambulatory BP monitoring.
The study was approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg 
(S-032/2009) and by local ethics committees in all participating centers, and parents or legal guardians provided 
informed written consent for study participation including permission of an arterial biopsy7. In a subproject of 
the 4 C study, patients with ESKD (but without prior renal replacement therapy) undergoing first-time kidney 
transplantation, Tenckhoff catheter insertion for peritoneal dialysis or fistula creation for hemodialysis and/or 
their guardians were asked to donate pieces of arterial tissue removed during the procedure for the study. All 
methods were performed in accordance with the relevant institutional guidelines and regulations.
Control populations. Children. Arterial control biopsies from children without CKD were obtained from 
the biobank of the National Register for Congenital Heart Defects, a national repository for medical data on 
patients with congenital heart defects in Germany. The collection of samples and provision for research studies 
is approved by the ethics committee of the Berlin Charité Medical Faculty (EA2/131/10) and informed written 
consent of patients and parents.
Adults. Control biopsies from adults without CKD were obtained from the Centre for Individualized Medicine 
in Arterial Diseases (CIMA) in Odense, Denmark. Repair arteries from coronary bypass surgery (internal tho-
racic artery) were collected at the Department of Thoracic, Heart and Vascular Surgery, Odense University 
Hospital, Denmark consecutively from 2008 to 2012. All participants gave written informed consent, and the 
study was approved by the Ethical Committee of Region Southern Denmark (S-20100044). Immediately after 
surgery, the internal thoracic artery was dissected free from the surrounding tissue. An arterial ring was cut and 
short term formalin-fixed (approximately 24 h in 4% buffered paraformaldehyde), then moved to a PBS solution 
and subsequently embedded in paraffin.
Rat aortas. Aortas from subtotally nephrectomized rats (n = 10) were obtained from a previous study10 and 
were processed like the human biopsies, including their application in a rat customized RT2 Profiler PCR Array 
(see below). All experimental protocols were approved by institutional review boards and state health authorities 
(LAGeSo; G0019/11). All animal experiments were conducted in accordance with local institutional guidelines 
for the care and use of laboratory animals.
Processing of arterial biopsies. Arterial biopsies were collected according to a standardized protocol. 
Biopsied vessels were gently cleaned of surrounding fat tissue, immediately cut up into 3 pieces and placed into 
vials containing 4% buffered formalin or RNAlater; the remaining tissue was immediately deep frozen in liquid 
nitrogen. Formalin-fixed samples were later embedded in paraffin, and deep frozen samples stored at −80 °C; all 
samples were sent to the study center in Berlin for further processing.
Paraffin embedded biopsies were investigated by histochemistry. The morphology of the biopsies was assessed 
using hematoxylin and eosin (H/E)-stained tissue sections. The H/E-stained sections were also used to determine 
the intima-media thickness (IMT). Using the Image J program 1.42q (National Institutes of Health, Bethesda, 
MD, USA), the distance from the lumen/intima edge to the media/adventitia edge of the arteries was measured 
at 12 different spots per arterial section and the average expressed as IMT (mean ± SD). The extent of media cal-
cifications was quantified by von Kossa- and alizarin red-staining and calcification positive areas were quantified 
using Image J software and expressed as percentage of total arterial wall area.
Cryoconserved biopsies were divided into two segments using a scissor. One part was used to determine the 
whole calcium content of the biopsies, the other part was used to isolate mRNA for gene expression studies.
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Determination of calcium content in biopsies. The cryoconserved biopsy segments were washed 
in calcium- and magnesium-free phosphate buffered saline and dried on Kimwipes® disposable wipers 
(Sigma-Aldrich, Deisenhofen, Germany). The segments were subsequently weighed and mixed with 100 µl 
0.1 mol/l HCl in a 1.5 ml reaction tube. After 18 h incubation at 20 °C, the tubes were vortexed and centrifuged 
for 30 s at 10.000 × g. Calcium contents in the supernatants were determined by cresolphthalein complexone 
chemistry (OCPC).
In parallel, the respective protein contents in the tissues were determined in the remaining sediments. After 
removing the HCl supernatants, the sediments were washed with demineralized water before 300 µl 0.1 mol/l 
NaOH/1% SDS were added. The mixture was homogenized by ultrasound, vortexed and then incubated for 1 h at 
20 °C. Afterwards, the probes were vortexed for 30 s at 10.000 × g and protein contents in the supernatants were 
determined using a BCA-kit (Thermo Fisher Scientific, Waltham, MA, USA).
The calcium content of each probe was finally normalized to the weight and to the protein content.
Customized PCR-Array. Only probes with sufficient tissue mass and with an unbroken cold chain were 
used for RNA isolation. A sufficient size of the probes was determined by a skillful molecular biologist on the 
basis of past experience. RNA was isolated using the Trizol reagent (Invitrogen, Carlsbad, California, USA) 
and phenol chloroform extraction. RNA quantity was estimated by a NanoDrop ND-1000 device (NanoDrop 
Technologies, Wilmington, NC). Isolated RNA with a ratio of absorbance at 260 nm and 280 nm of < 2 was not 
applied to the PCR array. Gene expressions in human and rat vessel biopsies were determined using a human/a 
rat customized RT2 Profiler PCR Array (Qiagen, Hilden, Germany). For the customized PCR array, all genes of 
interest were preselected by the authors. 500 ng RNA per probe were transcribed into cDNA using the RT2 First 
Strand Kit (Qiagen). The cDNA was mixed with the RT2 SYBR Green Master mix (Qiagen), loaded on the PCR 
array plate and the PCR was run on a MX3005 system (Agilent Technologies, Santa Clara, CA, USA).
The customized RT2 Profiler PCR Array plates (Qiagen) contained primers for 93 preselected genes including 
five housekeeping genes11 and internal controls. The acronyms and the respective full names of all genes are given 
in Supplementary Table S1. All expression data were calculated using the ΔΔCT method. Gene expressions 
in biopsies were normalized to the mean gene expressions of five housekeeping genes: HPRT1 (Hypoxanthine 
Phosphoribosyltransferase 1), PGK1 (Phosphoglycerate Kinase 1), EIF2B1 (Eukaryotic Translation Initiation 
Factor 2B Subunit Alpha), PPIA (Peptidylprolyl Isomerase A), and ELF1 (E74 Like ETS Transcription Factor 1). 
Relative gene expressions in the 4 C biopsies were determined by computing the ratio between the 4 C biopsies 
and the biopsies from the respective control populations.
To generalize the results of the gene expression studies, the preselected genes were clustered in different func-
tional categories such as extracellular matrix proteins or ion channels. This was done according to published 
evidence (see also the review by Rutsch et al.12) allowing a classification of the different genes.
Correlation studies. Vascular measurements performed at baseline and annually during follow-up in the 4 C 
study included echocardiography, 24-hour ambulatory blood pressure monitoring (ABPM), carotid ultrasound, 
and pulse wave velocity8. All examinations were performed in a standardized manner according to the study pro-
tocol and dedicated observer training, including measurement of resting BP as recommended by international 
guidelines13. To gain insights into relationships between specific genes, clinical parameters and the cardiovascu-
lar phenotype of the 4 C patients, we conducted correlation analyses with the last set of vascular measurements 
performed and with calculated progression of these measurements from baseline data at the time of enrollment.
Two-dimensional echocardiography images were obtained for the analysis of left ventricular (LV) volumes 
and left ventricular mass (LVM), which was calculated according to the Devereux formula14 and indexed to height 
2.7 (LVMI). The sex- and age-specific LVMI partition values of Khoury et al. were applied to define LV hyper-
trophy15. All ABPM measurements were performed using the same portable device type at all sites (Spacelabs 
90207–2Q) as described previously16. The carotid intima media thickness (cIMT) was obtained either by five 
averaged measurements on each side or semi-automatically using a portable ultrasound device (Acuson P50, 
Siemens) with integrated digital image evaluation software (Syngo US Workplace, Siemens Medical Solutions, 
USA Inc.); since cIMT in children changes with growth, reference values normalized for height and age were 
established in 1,155 healthy children aged 6–18 years17. The central pulse wave velocity (PWV) was measured 
with the oscillometric Vicorder device18, and compared to reference values normalized for height and age were 
established in a large European pediatric population (1003 healthy children aged 6–18 years)19. Data of BP, ABPM 
and vascular measurements was also expressed as standard deviation scores (SDS) indexed to gender and age or 
height8.
Statistics. Patient characteristics are provided as mean ± standard deviation or frequencies depending on 
the scale level of the data. Transcription levels and their ratios were analyzed for each individual gene by multiple 
two-sample t tests. Statistical significances with correction for multiple comparisons were determined by the 
Holm-Sidak method, with alpha = 5.0%. The Kruskal-Wallis test with Dunn’s post hoc multiple comparisons 
test was used to determine differences between calcium contents of the biopsy sample populations. The unpaired 
t-test with Welch’s correction was performed to analyze differences between IMT-values of biopsies. Spearman 
correlations were applied to analyze linear correlations between calcium contents and IMT values and correla-
tions between clinical parameters and levels of gene expression in arterial biopsies. All statistical calculations were 
performed with the GraphPad Prism-Software 6.01 (GraphPad Software, Inc., La Jolla, CA, USA).
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request
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Results
Patients. A total of 55 arterial biopsies from 4 C study patients were received from participating centres. Due 
to strict quality control measures including a non-interrupted cooling chain of cryoconserved probes and suffi-
cient material stored in RNAlater, only 26 probes were suitable for IMT and calcium measurements, of which only 
15 probes were suitable for PCR measurements.
These 15 children (10 male, 5 female) were 12.0 ± 3.4 years old and had an estimated glomerular filtration rate 
(eGFR) of 9.4 ± 3.2 ml/min/1.73 m2 at the time of biopsy. Serum levels of calcium (2.2 ± 0.2 mmol/l), phospho-
rus (1.7 ± 0.2 mmol/l) and parathormone (33.5 ± 23.5 pmol/l) were in the normal range. A variety of renal dis-
eases (Supplementary Table S2) had been diagnosed 3.6 ± 3.6 years prior to the time of biopsy. The biopsies were 
obtained from the inferior epigastric artery (n = 9, receiving a kidney transplant), omental artery (n = 4, starting 
peritoneal dialysis), and radial artery (n = 2).
For pediatric controls, we identified a total of 37 biopsies of aortic tissue from children collected during sur-
gical repair of congenital defects of the aorta or aortic valve. After excluding children younger than 1 year or with 
cyanotic or hypertensive heart disease or genetic disorders affecting the aortic arch, 20 biopsies were suitable to 
be used as controls. These biopsies were from 12 boys and 8 girls aged 3.9 ± 4.6 years.
Adult patients with coronary artery disease served as adult controls. A total of 11 biopsies of the internal 
thoracic artery, collected from non-diabetic patients (7 male, 4 female) aged 55 ± 9 years, were selected for com-
parison with the pediatric patients.
IMT and Calcium content of biopsies. Biopsies analyzed for IMT and calcium contents were from 26 
children aged 12.3 ± 3.3 years. They had CKD diagnosed 2.9 ± 3.1 years prior to study. The eGFR was 9.1 ± 3.5 ml/
min/1.73 m2. The biopsies were obtained from the inferior epigastric artery (n = 18, receiving a kidney trans-
plant), omental artery (n = 4, starting peritoneal dialysis), and radial artery (n = 4, starting hemodialysis).
The pediatric CKD biopsies showed no atherosclerotic lesions (Fig. 1A,B). The mean IMT of the biopsied 
vessels was 41.00 ± 21.19 µm, measuring about 25% of the IMT of adult control biopsies (161.00 ± 48.64 µm; 
Fig. 1C). Only incipient calcifications of the vessel walls were observed, and no overt calcifications were detectable 
by von Kossa staining while alizarin red–stained sections exhibited small areas of mineralized matrix representing 
2.5 ± 2.6% of the whole vessel area.
The mean calcium content of the 4 C study biopsies was 63.00 ± 49.94 µg calcium/mg protein and thus, well 
within the range of the control biopsies from adults (79.26 ± 20.97 µg calcium/mg protein). In contrast, the con-
trol biopsies from non-CKD children contained only 11.49 ± 6.87 µg calcium/mg protein. Thus, the calcium con-
tent of biopsies from children with CKD was increased ~5-fold compared to biopsies of children with normal 
kidney function (Fig. 1C).
The calcium contents of biopsies from CKD children correlated weakly with the respective IMT (Fig. 1D). Of 
note, in contrast to the calcium contents, the IMT of the 4 C biopsies were significantly lower than the respective 
values of the adult controls (Fig. 1E).
Figure 1. (A) H/E-stained arterial biopsy, CKD patient (female, age 13.7 years). Magnification: 10 × (left), 
40 × (right) (B) Von Kossa- (left) and alizarin red-staining (right) in adjacent slices of same biopsy. Von 
Kossa-stained calcified areas appear black while alizarin-red stained, areas appear dark-red (see arrows). 
Magnification: 10 × . (C) Calcium content of arterial vessel walls as determined by the OCPC method 
(Kruskall-Wallis test; global p-value: p = 0.0025). (D) Linear regression of vessel IMT with the corresponding 
OCPC-calcium contents in children with CKD (Spearman correlation coefficient). (E) IMT of biopsied vessels 
of children with CKD (4 C Study) and of adult non-CKD patients undergoing coronary bypass operation 
(Mann-Whitney test). Data are expressed as means ± SD.
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Gene expression in the 4 C biopsies. Gene expressions relative to housekeeping genes. According to their 
functionality, the 88 genes included in the customized array were clustered into different groups (Table 1) to facil-
itate the evaluation of the complex gene expression and correlation data sets. First, we determined whether genes 
in the 4 C biopsies have a higher or lower level of transcription compared to the mean gene expressions of five 
housekeeping genes. We found distinctly higher or lower expressions for 50 out of 88 analyzed genes. A distinctly 
higher level of transcription was observed for 18 genes (36%) and a distinctly lower level of transcription for 32 
genes (64%). 34% (17/50) of all these genes encoded for extracellular matrix (ECM) components (Table 2). The 
gene with the highest level of transcription (>1000-fold compared to the mean gene transcriptions of the house-
keeping genes) was matrix gla protein (MGP).
Gene expressions relative to pediatric controls. We next compared the gene expressions in the 4 C study biopsies 
with that of control biopsies from children without CKD (Table 3). Most of the significantly regulated genes 
(38%; 13/34) related to ECM turnover. The ECM components elastin (ELN), collagen type I (COL1A2), versican 
(VCAN) and the tissue inhibitor of matrix metalloproteinases type 2 (TIMP2) showed markedly downregulated 
expression Furthermore, genes encoding for key mediators of vascular smooth muscle cell (VSMC)-mediated 
vascular calcification such as osterix (SP7), runt-related transcription factor 2 (RUNX2) and the senescence 
marker cyclin-dependent kinase Inhibitor 2 A (CDKN2A) were highly upregulated, whereas the physiological 
artery calcification inhibitor ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) was significantly 
downregulated compared to the healthy control biopsies.
Pediatric CKD vs. adult non-CKD biopsies. We next analyzed differences in gene expression between pediat-
ric CKD biopsies and control biopsies from adults with classical atherosclerosis but normal kidney function. 
Transcription levels of 21 genes were significantly different between both groups. Thirteen out of these 21 genes 
(62%) were up- or downregulated in accordance with the gene expression ratios of pediatric CKD biopsies rel-
ative to pediatric controls (flagged green in Table 4). Furthermore, one third of the significantly regulated genes 
(7/21) were involved in ECM regulation. Of note the ratio of ADIPOQ, encoding for adiponectin, was 38. This 
indicates an upregulation of this adipokine which is considered to function as a physiological inhibitor of arterial 
calcification20.
Adult vs. pediatric controls. To investigate physiological age-related changes in gene expression, we compared 
the gene expression levels (which were normalized to the five housekeeping genes) between the pediatric and 
adult non-CKD controls. Differences were found particularly in the ECM gene cluster (Supplementary Table S3). 
Also, the pro-calcifying transglutaminase was much less expressed in pediatric controls compared to the adult 
biopsies. However, 70% of all analyzed genes (62/88) were not expressed significantly different between both 
control groups.
Comparison of human gene expression data with expression data from animal studies. To gain 
insights into similarities in CKD induced arterial gene expressions across species, we compared the expression 
data of the 4 C study biopsies with that obtained from rats after subtotal (5/6) nephrectomy (Table 5).
Altogether, 95% (18/19) of the significantly upregulated genes in humans were also upregulated in CKD rats. 
Of note, in contrast to the human vessels, the expression of the calcification inhibitor MGP was downregulated in 
rat aortas. Contrary to the high level of accordance in the upregulated genes, only 50% of the significantly down-
regulated genes in humans were also found downregulated in rats with CKD.
Functional category Genes
Vascular calcification SP7, RUNX2, CDKN2A, TGM2, BGLAP, S100A12
Extracellular matrix
CTGF, COL1A2, COL2A1, COL6A2, DDR1, VCAN, ELN, TIMP1, TIMP2, MMP1, MMP2, MMP3, 
MMP7, MMP8, MMP9, MMP14, ADAMTS7, VNN1, FBN1, HSPG2, ACAN, PPARG, HMGA1, 
EPHX2, HMGB1, COMP
Bone metabolism SOST, BMP1, BMP2, BMP3, BMP7
Physiological calcification inhibitors CA2, ANKH, TRIM24, ADIPOQ, HMOX1, FTL, TNFRSF11B, MGP, AHSG, ENPP1, SPP1
Ion channels TRPV5, TRPV6, KCNN4, KCNN3, KCNMA1, RYR3, S100G
Endoplasmic reticulum stress HSPA5, HSP90B1, DDIT3
Apoptosis CASP3, CASP8, BAX
Wnt signaling AXIN2, SFRP4, FGF2
NF-ĸB signaling MYD88, NFKB1, RELA
TGF-β signaling TGFB1, TGFBR1, TGFBR2, LTBP3, SMAD6
Inflammation IL10, TNF
NO synthases NOS2, NOS3, PRKG1, NOS1
Various FGF23, KL, VDR, AGTR2, ANGPT2, SLC25A15, ALPL, IFNG, AGER, CRP
Housekeeping genes HPRT1, PGK1, EIF2B1, PPIA, ELF1
Table 1. Genes included in customized PCR array*. *For abbreviations, see Supplemental Material.
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Rank Gene
Ratio 4 C vs. housekeeping 
(MEAN ± SD) Gene group
Genes with a high transcription level:
1 MGP 1184.2 ± 1241.88 Physiological calcification inhibitors
2 HMGB1 17.09 ± 16.90 Extracellular matrix
3 CTGF 16.51 ± 26.64 Extracellular matrix
4 COL1A2 12.53 ± 8.45 Extracellular matrix
5 HSP90B1 10.33 ± 7.88 Endoplasmic reticulum stress
6 SP7 6.22 ± 11.08 Vascular calcification
7 ADIPOQ 5.30 ± 6.89 Physiological calcification inhibitors
8 FBN1 4.71 ± 5.41 Extracellular matrix
9 TIMP2 4.69 ± 3.97 Extracellular matrix
10 ELN 4.62 ± 6.32 Extracellular matrix
11 COL6A2 3.42 ± 3.20 Extracellular matrix
12 TGM2 3.32 ± 3.90 Extracellular matrix
13 MMP2 2.91 ± 2.70 Extracellular matrix
14 TGFBR2 2.80 ± 3.14 TGF-β signaling
15 DDIT3 2.68 ± 2.02 Endoplasmic reticulum stress
16 FTL 2.43 ± 2.18 Physiological calcification inhibitors
17 KCNMA1 2.43 ± 1.89 Ion channels
18 FGF2 1.81 ± 1.22 Wnt-pathway
Genes with a low transcription level:
1 BMP2 0.06 ± 0.09 Bone metabolism
2 DDR1 0.08 ± 0.08 Extracellular matrix
3 SMAD6 0.08 ± 0.08 TGF-β signaling
4 ACAN 0.10 ± 0.11 Extracellular matrix
5 BMP7 0.12 ± 0.21 Bone metabolism
6 KCNN4 0.13 ± 0.19 Ion channels
7 KCNN3 0.13 ± 0.21 Ion channels
8 ALPL 0.15 ± 0.21 Various
9 HMGA1 0.16 ± 0.21 Extracellular matrix
10 TNF 0.18 ± 0.21 Inflammation
11 IFNG 0.18 ± 0.37 Various
12 VDR 0.20 ± 0.29 Various
13 NOS3 0.20 ± 0.14 NO-synthases
14 RYR3 0.20 ± 0.14 Ion channels
15 KL 0.21 ± 0.29 Various
16 VNN1 0.28 ± 0.49 Extracellular matrix
17 NFKB1 0.31 ± 0.21 NF-κB signaling
18 IL10 0.32 ± 0.38 Inflammation
19 HMOX1 0.33 ± 0.36 Physiological calcification inhibitors
20 BMP3 0.33 ± 0.33 Bone metabolism
21 AXIN2 0.34 ± 0.59 Wnt signaling
22 VCAN 0.37 ± 0.49 Extracellular matrix
23 MMP14 0.40 ± 0.56 Extracellular matrix
25 CASP8 0.41 ± 0.40 Apoptosis
26 TNFRSF11B 0.44 ± 0.60 Physiological calcification inhibitors
27 MMP9 0.44 ± 0.49 Extracellular matrix
28 CASP3 0.44 ± 0.55 Apoptosis
29 BGLAP 0.45 ± 0.58 Vascular calcification
30 CDKN2A 0.45 ± 0.48 Vascular calcification
31 AGER 0.48 ± 0.56 Various
32 ADAMTS7 0.49 ± 0.65 Extracellular matrix
Table 2. Genes with high and low transcription levels in 4 C study biopsies*. *The data are sorted by the 
magnitude of the ratio of gene expression. Transcription levels and their ratios were analyzed for each individual 
gene by comparing 4 C and housekeeping genes.
7Scientific RepoRts |         (2019) 9:10316  | https://doi.org/10.1038/s41598-019-46805-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
Gene expressions in vessel biopsies depending on their calcium content. We further ana-
lyzed the gene expressions within the CKD biopsies to test whether differences due different calcium contents 
(OCPC-method) could be observed. At first, the 4 C study biopsies were divided into groups with more or less 
than 80 µg calcium/mg protein, an arbitrary cutoff derived from the average calcium concentration in the biopsies 
from adults without CKD. Five genes were expressed significantly more strongly in probes with higher calcium 
contents. These were DNA Damage Inducible Transcript 3 (DDIT3), a regulator of endoplasmic reticulum stress 
with subsequent induction of apoptosis and the pro-apoptotic Bcl-2-associated X protein (BAX). Further, the 
physiological calcification inhibitor ferritin (FTL) as well as COL6A2 and RELA were more strongly expressed. 
The respective proteins are involved e.g. in VSMC anchoring in the tunica media (collagen VI) and in NF-κB 
signaling (RELA/p65) and their upregulation considered protective21,22 (Supplementary Fig. S1).
We then performed a correlation analysis between the expression data of all genes with the respective calcium 
contents as determined by the OCPC method. As shown in Supplementary Table S4, five genes (DDIT3, FTL, 
HSPG2, MYD88, TIMP2) were significantly correlated with higher calcium contents.
Association of arterial tissue gene expression and clinical phenotype. We next investigated 
whether altered gene transcription in pediatric CKD biopsies (compared with pediatric controls; Table 3) 
correlated with clinical data (complete variables listed in Supplementary Table S5). The resulting correlation 
Rank Gene
Ratio 4 C vs. non-CKD 
children(MEAN ± SD) p-value Gene-group
Significantly upregulated genes
1 SP7 247.55 ± 644.48 0.0171 Vascular calcification
2 MMP7 70.81 ± 174.42 0.0174 Extracellular matrix
3 NOS2 35.83 ± 97.95  < 0.0001 NO-Synthases
4 RUNX2 24.76 ± 67.45 0.0017 Vascular calcification
5 VNN1 23.89 ± 62.64 0.0394 Extracellular matrix
6 CDKN2A 15.23 ± 25.45 0.0007 Vascular calcification
7 COL2A1 15.20 ± 37.29 0.0146 Extracellular matrix
8 IL10 11.33 ± 27.48 0.0037 Inflammation
9 AGTR2 10.87 ± 33.75 0.0211 Various
10 TNF 8.29 ± 19.54 0.0033 Inflammation
11 BMP3 7.91 ± 19.94 0.0151 Bone metabolism
12 TRPV6 7.66 ± 18.55 0.0024 Ion channels
13 KCNN3 6.60 ± 17.93 0.0281 Ion channels
14 PPARG 5.99 ± 17.96 0.0025 Extracellular matrix
15 MGP 5.20 ± 10.18 0.0018 Physiological calcification inhibitors
16 KCNN4 4.96 ± 12.12 0.0303 Ion channels
17 S100A12 4.84 ± 16.05 0.0023 Vascular calcification
18 HMGB1 4.73 ± 5.78 0.0011 Extracellular matrix
19 CA2 3.61 ± 7.53 0.0125 Physiological calcification inhibitors
20 HMGA1 3.58 ± 7.10 0.0154 Extracellular matrix
21 KL 3.40 ± 6.65 0.0252 Various
22 FGF2 3.09 ± 3.16 0.0001 Wnt-pathway
23 DDIT3 1.66 ± 2.20 0.0491 Endoplasmic reticulum stress
Significantly downregulated genes
1 ELN 0.01 ± 0.04 0.0088 Extracellular matrix
2 COL1A2 0.07 ± 0.11  < 0.0001 Extracellular matrix
3 VCAN 0.18 ± 0.38 0.0065 Extracellular matrix
4 TIMP2 0.27 ± 0.30  < 0.0001 Extracellular matrix
5 LTBP3 0.30 ± 0.62 0.0091 TGF-β signaling
6 ENPP1 0.31 ± 0.72 0.0064 Physiological calcification inhibitors
7 TIMP1 0.42 ± 0.79 0.0085 Extracellular matrix
8 COL6A2 0.45 ± 0.87 0.0405 Extracellular matrix
9 MMP2 0.47 ± 0.66 0.0048 Extracellular matrix
10 BMP1 0.49 ± 0.82 0.0401 Bone metabolism
11 HSP90B1 0.58 ± 0.68 0.0061 Endoplasmic reticulum stress
Table 3. Significantly altered gene transcription in 4 C study biopsies relative to pediatric controls*. *The data are 
sorted by the magnitude of the ratio of gene expression. Transcription levels and their ratios were analyzed for each 
individual gene by multiple two-sample t- tests comparing 4 C and non-CKD children. Statistical significances 
with correction for multiple comparisons were determined by the Holm-Sidak method, with alpha = 5.0%.
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coefficients and the respective p values are shown in Table 6. The LVMI of the CKD patients at baseline was neg-
atively correlated with the upregulated genes KCNN3, FGF2 and with the downregulated genes VCAN, TIMP2, 
ENPP1, LTBP3, MMP2, HSP90B1, and TIMP1, whereas the change in LVMI during follow-up was negatively 
associated with only one upregulated gene, SP7.
The cIMT values of the 4 C patients at baseline showed a significantly positive correlation with the upregulated 
genes IL10, TNF, CA2, CDKN2A and FGF2 and with the downregulated genes ENPP1 and VCAN. The change 
in cIMT during follow-up (slope_cIMT_SDS_monthly) showed significant positive correlations with the upreg-
ulated genes TNF, IL10, CA2, HMGA1, VNN1 and FGF2 and with the downregulated genes BMP1 and VCAN 
(Fig. 2).
Discussion
In this study, arterial biopsies from children with ESKD showed increased calcium contents and significant alter-
ations in gene transcription such as upregulation of calcification inhibitors and extracellular matrix genes. Most 
observed changes in gene expression were reproducible in the uremic rat model. The changes in arterial gene 
transcription were frequently associated with cardiovascular phenotypes.
Calcium accumulation is the dominant finding in incipient remodeling. Arterial tissue calcium 
levels were increased ~5-fold in the children with ESKD compared to children with normal kidney function and 
were comparable to adults (age >50) with classical atherosclerosis. The massively increased calcium load went 
along with an increased IMT of the biopsied arteries, i.e. vascular remodeling.
The gene expression analyses reflected these early changes in the vessels of the 4 C patients. The expressions 
of DDIT3, FTL, perlecan (HSPG2), MYD88 and TIMP-2 were positively correlated with arterial calcium con-
tent. The apoptosis promoting activity of DDIT323,24 may actively contribute to mineralization of the matrix by 
VSMC25. TIMP-2 is a multifunctional protein and has been found positively associated with calcification in radial 
artery explants of uremic patients26. In contrast, FTL (ferritin) and the matrix proteoglycan HSPG2 (perlecan) are 
Rank Gene
Ratio 4 C vs. adult 
controls (MEAN ± SD) p-value Gene-group Flag
Significantly upregulated genes
1 ADIPOQ 37.89 ± 149.38 0.0498 Physiological calcification inhibitors ≠
2 NOS2 25.63 ± 66.88 0.0129 NO-Synthases ✓
3 MMP9 21.89 ± 68.26 0.0438 Extracellular matrix ≠
4 RUNX2 17.36 ± 47.56 0.0279 Vascular calcification ✓
5 TRPV6 16.75 ± 46.19 0.0200 Ion channels ✓
6 IL10 16.08 ± 51.00 0.0440 Inflammation ✓
7 PPARG 15.34 ± 48.09 0.0114 Extracellular matrix ✓
8 S100A12 11.59 ± 37.29 0.0051 Vascular calcification ✓
9 BMP3 6.54 ± 19.62 0.0338 Bone metabolism ✓
10 HMOX1 5.58 ± 10.71 0.0312 Physiological calcification inhibitors ≠
11 MGP 3.76 ± 6.02 0.0309 Physiological calcification inhibitors ✓
12 HMGB1 2.93 ± 4.05 0.0491 Extracellular matrix ✓
13 FGF2 2.88 ± 3.85 0.0092 Wnt signaling ✓
Significantly downregulated genes
1 TIMP2 0.19 ± 0.34 0.0263 Extracellular matrix ✓
2 KCNMA1 0.24 ± 0.30 0.0005 Ion channels ≠
3 KCNMA1 0.24 ± 0.30 0.0005 Ion channels ≠
4 SFRP4 0.25 ± 0.37 0.0030 Wnt signaling ≠
5 TIMP1 0.37 ± 0.78 0.0294 Extracellular matrix ✓
6 RYR3 0.37 ± 0.51 0.0362 Ion channels ≠
7 FTL 0.39 ± 0.63 0.0093 Extracellular matrix ≠
8 COL1A2 0.40 ± 0.60 0.0130 Extracellular matrix ✓
Table 4. Significantly altered gene transcription in 4 C study biopsies relative to adult non-CKD controls*. *The 
data are sorted by the magnitude of the ratio of gene expression Ratios (CKD children vs. adult controls) were 
compared by two-sample t-tests using the Holm-Sidak method for multiplicity correction with alpha = 5.0%. 
Multiplicity adjusted p-values are reported. Flags indicate similarities (✓) and non-similarities (≠) in the 
direction of regulation. For example, NOS2 is significantly upregulated in 4 C patients relative to pediatric and 
adult controls (by a factor of 35 and 25, respectively). In contrast, SP7 is significantly upregulated relative to 
pediatric controls (247.55 ± 644.48; p = 0.0171) but not relative to adult controls (24.90 ± 107.06; p = 0.1046; 
not shown).
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considered to have protective function in the vascular wall by inhibiting various pathobiological processes induc-
ing calcification27,28. The myeloid differentiation factor MYD88 initiates a pathway resulting in the activation of 
nuclear factor-kappaB (NF-ĸB) and the production of various proinflammatory mediators. Thus, the correlation 
of gene transcripts with calcium content in pediatric biopsies indicate the upregulation of pro-calcifying and 
inflammatory mechanisms but also of calcification inhibitors.
The comparison of gene transcription levels with the pediatric control population further corroborates the 
upregulation of pro-calcifying factors. The transcription factor SP7 showed the most marked increase in gene 
expression in the 4 C biopsies (200-fold). This is in line with the central role of SP7 during the transdifferentiation 
of VSMC to an osteogenic phenotype which is significantly involved in the development of calcifications25. The 
upregulation of MMP-7 (70-fold) and Runx2 (24-fold) are additional indications of the pro-calcifying state.
A further interesting finding was the ~15-fold upregulation of CDKN2A, a regulator of cellular apoptosis and 
senescence, which is in line with a role for its encoded protein p16INK4a in promoting premature arterial ageing 
in CKD patients29.
Altogether, these data delineate mechanisms of “native” CKD induced accelerated arterial calcification, stiff-
ness and ageing.
Rank Gene Flag
Significantly upregulated genes:
1 SP7 ✓
2 MMP7 ✓
3 NOS2 ✓
4 RUNX2 ✓
5 VNN1 ✓
6 CDKN2A ✓
7 COL2A1 ✓
8 IL10 ✓
9 AGTR2 ✓
10 TNF ✓
11 BMP3 ✓
12 TRPV6 ✓
13 KCNN3 ✓
14 PPARG ✓
15 MGP ≠
16 KCNN4 ✓
17 S100A12
18 HMGB1
19 CAR2 ✓
20 HMGA1
21 KL ✓
22 FGF2 ✓
23 DDIT3
Significantly downregulated genes:
Rank Gene Flag
1 ELN ≠
2 COL1A2 ✓
3 VCAN ≠
4 TIMP2 ✓
5 LTBP3 ≠
6 ENPP1 ≠
7 TIMP1 ✓
8 COL6A2 ≠
9 MMP2 ≠
10 BMP1 ✓
11 HSP90B1 ✓
Table 5. Comparison of significantly altered gene transcriptions in children with terminal CKD (relative 
to pediatric controls) and rats with subtotal nephrectomy (relative to sham)*. *Gene transcriptions were 
compared between up- and downregulated genes regarding similarities (✓) and non-similarities (≠). The 
data are sorted by the magnitude of the gene expressions. Notably, the gene expressions of DDIT3, S100A12, 
HMGB1 and HMGA1 were not determined in the rat customized PCR-array.
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Rank Gene Correlation with
Correlation 
coefficient p-value Gene-group
Correlations of significantly upregulated genes
1 KCNN3 BMI SDS −0.5627 0.0233 Ion channels
1 IL10 cIMT 0.8120 0.0005 Inflammation
2 TNF cIMT 0.6703 0.0147 Inflammation
3 CA2 cIMT 0.6328 0.0236 Physiological calcification inhibitors
4 CDKN2A cIMT 0.6241 0.0254 Vascular calcification
5 FGF2 cIMT 0.6161 0.0288 Wnt-pathway
1 NOS2 cIMT SDS −0.6490 0.0374 NO-synthases
1 KCNN3 LVMI −0.6124 0.0152 Ion channels
2 FGF2 LVMI −0.5455 0.0354 Wnt-pathway
1 COL2A1 PWV SDS 0.6083 0.0124 Extracellular matrix
2 TRPV6 PWV SDS 0.5266 0.0361 Ion channels
1 TNF slope_cIMT_SDS 0.8398 0.0046 Inflammation
2 IL10 slope_cIMT_SDS 0.8218 0.0066 Inflammation
3 CA2 slope_cIMT_SDS 0.7833 0.0125 Physiological calcification inhibitors
4 HMGA1 slope_cIMT_SDS 0.7030 0.0346 Extracellular matrix
5 VNN1 slope_cIMT_SDS 0.7030 0.0346 Extracellular matrix
6 FGF2 slope_cIMT_SDS 0.6778 0.0448 Wnt-pathway
1 SP7 slope LVMI −0.5849 0.0457 Vascular calcification
1 NOS2 Uric acid 0.5614 0.0236 NO-synthases
2 SP7 Uric acid 0.4974 0.0499 Vascular calcification
1 DDIT3 cFGF-23 −0.5784 0.0239 Endoplasmatic reticulum stress
1 FGF2 Years since CKD diagnosis 0.6269 0.0093 Wnt-pathway
2 MGP Years since CKD diagnosis 0.5546 0.0258 Physiological calcification inhibitors
Correlations of significantly downregulated genes
1 ELN Age −0.5274 0.0358 Extracellular matrix
1 TIMP2 BMI SDS 0.6833 0.0045 Extracellular matrix
2 VCAN BMI SDS −0.5770 0.0193 Extracellular matrix
3 MMP2 BMI SDS −0.5270 0.0360 Extracellular matrix
1 COL6A2 CAKUT diagnosis −0.5272 0.0358 Extracellular matrix
2 RELA CAKUT diagnosis −0.5142 0.0416 NF-κB signaling
1 RELA cFGF-23 −0.5763 0.0245 NF-κB signaling
1 ENPP1 cIMT 0.6249 0.0256 Physiological calcification inhibitors
2 VCAN cIMT 0.5923 0.0362 Extracellular matrix
1 ENPP1 cIMT SDS −0.8092 0.0026 Physiological calcification inhibitors
1 VCAN LVMI −0.7438 0.0015 Extracellular matrix
2 TIMP2 LVMI −0.6364 0.0021 Extracellular matrix
3 ENPP1 LVMI −0.6462 0.0093 Physiological calcification inhibitors
4 LTBP3 LVMI −0.6369 0.0107 TGF-β pathway
5 MMP2 LVMI −0.6160 0.0145 Extracellular matrix
6 HSP90B1 LVMI −0.6011 0.0178 Endoplasmic reticulum stress
7 TIMP1 LVMI −0.5532 0.0324 Extracellular matrix
1 COL1A2 25-OHD-Vitamin D3 0.5085 0.0443 Extracellular matrix
1 VCAN iPTH −0.5534 0.0262 Extracellular matrix
1 BMP1 Slope cIMT SDS 0.8513 0.0036 Bone metabolism
2 VCAN Slope cIMT SDS 0.6908 0.0394 Extracellular matrix
1 COL6A2 Slope mean 24 h MAP_SDS 0.6205 0.0417 Extracellular matrix
1 TIMP1 Slope PWV SDS 0.5767 0.0391 Extracellular matrix
Table 6. Significant correlations between significantly altered gene expressions in 4C-biopsies (compared to 
pediatric controls) and 4 C patient data*. *Data are sorted by the respective strength of the correlations with the 
clinical parameters. Abbreviations: BMI SDS: standard deviation score (SDS) of the body mass index; CAKUT: 
diagnosis of CAKUT (congenital anomaly of the kidneys and urinary tract); cIMT: carotid intima-media 
thickness; cIMT_SDS: the SDS of cIMT; LVMI: left ventricular mass index; PWV-SDS: standard deviation score 
of the pulse wave velocity; slope_cIMT_SDS: monthly change in cIMT-SDS; slope mean24MAP_SDS: monthly 
change in mean 24-hour arterial blood pressure SDS; slope LVMI: change in LVMI; slope_PWV SDS: monthly 
change in PWV SDS; years_since_ckd_diagnosis: known duration of CKD.
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Strong upregulation of calcification inhibitors. Within the 4 C study biopsies we found a very high 
transcription of MGP, a potent calcification inhibitor30, compared to gene expressions of the five housekeeping 
genes. This is of interest, since previous studies showed an increased MGP expression in vitro in response to 
mineralization31. Similarly, the enhanced expression levels of FTL and HSPG2 suggest compensatory protec-
tive upregulation. During the onset of calcification, FTL exerts protective effects by its ferroxidase-activity27 and 
HSPG2 is involved in the maintenance of the vessel integrity32. In addition, we found a significant upregulation of 
Surrogate 
marker
Significant correlaons with gene transcripons
Upregulated gene 
expression
downregulated gene 
expression
LVMI
Progression 
of LVMI
cIMT
Monthly 
progression 
of cIMT
PWV-SDS
Monthly 
progression 
of PWV
Figure 2. Overview of significantly regulated gene transcripts and their associations with surrogate markers of 
CVD. Abbreviations: cIMT, Carotid intima media thickness (A. Carotis); LVMI, Left ventricular mass index; 
PWV, Pulse wave velocity; PWV-SDS, Pulse wave velocity standard deviation score.
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vascular gene expression of CA2, (carbonic anhydrase 2), HMOX1 (heme oxygenase-1) and ADIPQ (adiponec-
tin), in 4 C study children relative to adult controls. These genes are involved in the prevention of calcification by 
preventing cellular calcium uptake33 and osteoblast transformation of VSMC, respectively27,34.
In a previous study of children with ESKD including dialyzed patients, the arterial calcium load was strik-
ingly higher in dialysis compared to pre-dialysis patients35. Our findings suggest that the upregulation of inhib-
itors might protect most pediatric patients from acquiring overt calcifications during the pre-dialysis stage; 
dialysis–related mechanisms (such as induction of apoptosis) may overcome this protection. In our study, the 
anti-inflammatory and anti-apoptotic cytokine IL-10 showed the highest level of significance of all variables asso-
ciated with cIMT and change in cIMT with time in the pediatric ESKD patients. Upregulation of this pluripotent 
immunoregulatory cytokine (relative to both pediatric and adult controls) could constitute an additional com-
pensatory protective mechanism and one might speculate that similarly to the upregulation of calcification inhib-
itors, this could be overcome by dialysis – induced inflammatory and apoptotic signals. However, this hypothesis 
needs confirmation by futher studies.
Arterial remodeling in CKD starts in the matrix. Modification and reorganization of the ECM is one 
of the earliest steps in hypertensive vascular remodelling and atherosclerotic cardiovascular disease36. Likewise, 
ECM proteins may be essentially involved in CKD-induced arterial remodeling, as suggested by the fact that 
about one third of all significantly regulated genes (in biopsies of 4 C study patients relative to pediatric controls) 
were ECM genes. Of note, ~46% (21/46) of the analyzed transcripts showing significant associations with cardio-
vascular studies in the pediatric ESKD patients are coding for ECM proteins.
We have previously demonstrated that MMPs play a pivotal role in initiating vascular calcifications in an 
animal model of CKD10. Based on these studies, we expected significant transcriptional changes in MMPs as 
important contributors to vascular ECM remodeling. However, in the pediatric ESKD biopsies this could only 
be confirmed for MMP-2 (0.48-fold) while MMP-9 was not significantly regulated compared to the control pop-
ulation. Of interest, MMP-7 expression was highly upregulated in the 4 C study biopsies. In elderly patients with 
advanced carotid stenosis, high levels of MMP-7 were found in atherosclerotic plaques and considered to promote 
inflammatory responses and plaque instability37. Altogether, one third of the significantly regulated genes in the 
pediatric patients relative to adult controls code for ECM proteins. This could suggest a more pronounced matrix 
involvement in incipient CKD-induced arteriopathy compared to established classical atherosclerosis.
CKD induces similar transcriptional changes in humans and rats. To address an important aspect 
of preclinical research, we additionally compared the gene expression data from the 4 C biopsies with respective 
gene expressions in arteries from rats with CKD. The high concordance (95%) in the group of significantly upreg-
ulated genes and at least 50% conformity in the group of downregulated genes support the validity of our findings 
across species and the relevance of experimental rodent models of CKD for the study of CKD associated CVD.
Association studies confirm the significance of transcriptional changes. We observed some highly 
significant associations between arterial gene expression and clinical markers of 4 C patients.
The LVMI at baseline, the surrogate marker of CVD showing the greatest increase with each CKD stage in the 
4 C study8 was significantly associated with the expression levels of several genes in arterial biopsies, indicating 
their shared involvement in arterial and ventricular remodeling in CKD. However, the change in LVMI during 
follow-up was only associated (negatively) with the transcription level of a single gene, the transcription factor 
osterix. Thus, transcription levels in arterial biopsies provided relatively little information regarding the further 
development of cardiac changes in children with CKD.
In contrast and of particular interest is the observed association of certain tissue transcriptomic changes with 
the dynamics of carotid IMT thickening documented in the longitudinal clinical study. This parameter indicates 
the progression of the age-matched cIMT during the prospective observational study. Several significant positive 
correlations suggest that inflammatory processes (TNF, IL-10), calcification inhibitors (CA2), the Wnt-pathway 
(FGF-2) and foremost, ECM components (HMGA1, VNN1, VCAN), impact the pathophysiological responses in 
arteries from children with CKD.
Although standardized systolic blood pressure was the single independent factor significantly associated with 
all vascular measurements at baseline of the 4 C study8 (indicating an extraordinary impact of blood pressure on 
the cardiovascular phenotype of CKD patients), we could not detect significant associations of blood pressure 
parameters with arterial gene transcription levels in the present study. A weakly positive correlation of collagen 
6A2 gene expression with the change in mean 24-hour arterial blood pressure was the only exception. These find-
ings could indicate that CKD induced vascular remodeling (of peripheral arteries) in the early stage is primarily 
driven by other factors such as calcium accumulation and matrix rearrangement.
Limitations. A limitation of the present study is the relatively small number of biopsies included, due to strict 
quality control of the biopsy material. The study may be further limited by the age differences of the pediatric 
patient groups and it cannot be ruled out that in the control group, aortic gene expression may have been affected 
by the presence of the underlying cardiac abnormality, although care was taken in the selection of patients. While 
it could be argued that aortic tissue (from pediatric controls) is physiologically different from muscular artery 
tissue (from CKD patients), there is general consensus that CKD-related arterial remodeling is a systemic process 
affecting conduit and muscular arteries38. This notion is further supported by data of this study showing simi-
larities in gene expression changes in human medium-sized arteries and murine aortas after 5/6 nephrectomy, 
the a widely used animal model for cardiovascular research in CKD. Moreover, customized PCR analysis is a 
pre-selective, hypothesis-driven approach focusing on proteins known to be involved in vascular remodeling 
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and calcification-associated mechanisms; with this approach we may have missed detection of as yet unknown 
mechanisms. However, in view of the expected small number of available biopsies, an untargeted approach using 
a whole genome array would likely have produced a high number of false-negative results and thus, a lower detec-
tion rate. It should also be acknowledged that correlations with gene transcription levels indicate associations but 
not causal relationships.
Conclusions
CKD-induced arterial disease in children with predialysis ESKD is characterized by calcium accumulation, 
matrix remodeling, increased stiffness and premature ageing. By measuring arterial gene transcription levels of 
proteins involved in vascular remodeling, we have characterized molecular mechanisms of CKD-induced arte-
riopathy at the earliest stage and demonstrated the pathophysiological importance of these genes in relation to 
the clinical phenotype. Our study provides insights that can serve to initiate further studies of the progression of 
arterial and cardiac remodeling in patients with CKD.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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